Indazolyl- and indolyl-benzamide derivatives
US10246421B2 · kind B2 · utility
0Cited by
4References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 11, 2015 |
| Grant date | Apr 2, 2019 |
| Priority date | — |
| Expiry date | Sep 11, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to indazolylbenzamide, indolylbenzamide, benzo[d]imidazolyl-benzamide, and benzo[d]triazolylbenzamide derivatives of formula useful in the treatment and/or prevention of diseases and/or conditions related to cell proliferation, such as cancer, infection, inflammation and inflammation-associated disorders, and conditions associated with angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.